Stay updated on SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial

Sign up to get notified when there's something new on the SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision updated from v3.6.3 to v3.6.4, indicating an internal platform update; no visible changes to study details or layout are indicated by the changes provided.
    Difference
    0.0%
    Check dated 2026-07-28T04:59:53.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    A new revision tag, v3.6.3, was added to the page, replacing the previous v3.6.2. This indicates an updated version of the study record.
    Difference
    0.0%
    Check dated 2026-07-06T16:10:18.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The page revision tag changed from v3.6.0 to v3.6.2, indicating a version update of the study record. No substantive study content or user-facing details were modified.
    Difference
    0.0%
    Check dated 2026-06-29T08:53:24.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The page adds a recruitment status note signaling that participants are no longer being sought, and adds new help and navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). It also updates the Intervention/Treatment heading formatting and the site revision label to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-15T08:10:54.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The page revision has been updated from v3.5.4 to v3.5.5, representing a new patch/version of the ClinicalTrials.gov record. This likely accompanies small edits or improvements to the page layout or metadata, while the study details themselves remain unchanged.
    Difference
    0.0%
    Check dated 2026-06-08T04:20:08.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.4, indicating a backend/template update. This change does not modify the displayed study details or navigation.
    Difference
    0.0%
    Check dated 2026-05-17T10:16:11.000Z thumbnail image

Stay in the know with updates to SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial page.